
ERBB family receptor tyrosine kinases are overexpressed in a significant subset of breast cancers. One of these receptors, HER2/neu, or ErbB-2, is the target for a new rational therapeutic antibody, Herceptin. Other inhibitors that target this receptor, and another family member, the epidermal growth factor (EGF) receptor, are moving into clinical trials. Both of these receptors are sometimes overexpressed in breast cancer, and still subject to regulation by hormones and other physiological regulators. Optimal use of therapeutics targeting these receptors will require consideration of the several modes of regulation of these receptors and their interactions with steroid receptors.
Transcriptional Activation, Epidermal Growth Factor, Receptor, ErbB-2, Genes, erbB, Gene Amplification, Antibodies, Monoclonal, Gene Expression Regulation, Developmental, Breast Neoplasms, Review, Protein-Tyrosine Kinases, Trastuzumab, Antibodies, Monoclonal, Humanized, ErbB Receptors, Gene Expression Regulation, Neoplastic, Transforming Growth Factors, Humans, Female, Biomarkers, Signal Transduction
Transcriptional Activation, Epidermal Growth Factor, Receptor, ErbB-2, Genes, erbB, Gene Amplification, Antibodies, Monoclonal, Gene Expression Regulation, Developmental, Breast Neoplasms, Review, Protein-Tyrosine Kinases, Trastuzumab, Antibodies, Monoclonal, Humanized, ErbB Receptors, Gene Expression Regulation, Neoplastic, Transforming Growth Factors, Humans, Female, Biomarkers, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 141 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
